Found: 25
Select item for more details and to access through your institution.
Human T lymphocyte clones reactive in primed lymphocyte typing and cytotoxicity.
- Published in:
- Nature, 1979, v. 281, n. 5729, p. 307, doi. 10.1038/281307a0
- By:
- Publication type:
- Article
Repetitive Weekly Cycles of Interleukin-2. II. Clinical and Immunologic Effects of Dose, Schedule, and Addition of Indomethacin2.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 18, p. 1451
- By:
- Publication type:
- Article
Repetitive Weekly Cycles of Recombinant Human Interleukin-2: Responses of Renal Carcinoma With Acceptable Toxicity2.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 1, p. 60
- By:
- Publication type:
- Article
Radiation Augments the Local Anti-Tumor Effect of In Situ Vaccine With CpG-Oligodeoxynucleotides and Anti-OX40 in Immunologically Cold Tumor Models.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.763888
- By:
- Publication type:
- Article
Clinical response of a patient with diffuse histiocytic lymphoma to adoptive chemoimmunotherapy using cyclophosphamide and alloactivated haploidentical lymphocytes. A case report and phase I trial.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1647, doi. 10.1007/s00262-018-2223-z
- By:
- Publication type:
- Article
Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 12, p. 1523, doi. 10.1007/s00262-016-1904-8
- By:
- Publication type:
- Article
Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansion.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 9, p. 1047, doi. 10.1007/s00262-016-1864-z
- By:
- Publication type:
- Article
Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 8, p. 897, doi. 10.1007/s00262-016-1846-1
- By:
- Publication type:
- Article
Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the Hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survival.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 8, p. 1303, doi. 10.1007/s00262-013-1430-x
- By:
- Publication type:
- Article
Phase II trial of hu14.18-IL2 for patients with metastatic melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2261, doi. 10.1007/s00262-012-1286-5
- By:
- Publication type:
- Article
Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 12, p. 1789, doi. 10.1007/s00262-011-1072-9
- By:
- Publication type:
- Article
The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 5, p. 731, doi. 10.1007/s00262-011-0971-0
- By:
- Publication type:
- Article
Intratumoral immunocytokine treatment results in enhanced antitumor effects.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 12, p. 1891, doi. 10.1007/s00262-008-0519-0
- By:
- Publication type:
- Article
Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 7, p. 761, doi. 10.1007/s00262-005-0069-7
- By:
- Publication type:
- Article
NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 1, p. 41, doi. 10.1007/s00262-003-0435-2
- By:
- Publication type:
- Article
A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group.
- Published in:
- 1997
- By:
- Publication type:
- journal article
A phase II trial of human recombinant interleukin-2 administered as a 4-day continuous infusion for children with refractory neuroblastoma, non-Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A Childrens Cancer Group study.
- Published in:
- 1995
- By:
- Publication type:
- journal article
The influence of autologous lymphokine-activated killer cell infusions on the toxicity and antitumor effect of repetitive cycles of interleukin-2.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Rhamnose Glycoconjugates for the Recruitment of Endogenous Anti-Carbohydrate Antibodies to Tumor Cells.
- Published in:
- ChemBioChem, 2014, v. 15, n. 10, p. 1393, doi. 10.1002/cbic.201402019
- By:
- Publication type:
- Article
Antibody landscape of C57BL/6 mice cured of B78 melanoma via a combined radiation and immunocytokine immunotherapy regimen.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1221155
- By:
- Publication type:
- Article
A phase Ib/II trial of granulocyte-macrophage-colony stimulating factor and interleukin-2 for renal cell carcinoma patients with pulmonary metastases: a case of fatal central nervous system thrombosis.
- Published in:
- 2000
- By:
- Publication type:
- journal article
HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.00675
- By:
- Publication type:
- Article
Influence of the Virulence of Mycobacterium tuberculosis on Protection Induced by Bacille Calmette-Guerin in Guinea Pigs.
- Published in:
- Journal of Infectious Diseases, 1981, v. 143, n. 5, p. 734
- By:
- Publication type:
- Article
NK cell-mediated antibodydependent cellular cytotoxicity in cancer immunotherapy.
- Published in:
- Frontiers in Immunology, 2015, p. 1, doi. 10.3389/fimmu.2015.00368
- By:
- Publication type:
- Article